Mr. Wu’s Journey Through a Pioneering Minimally Invasive Heart Procedure

Shanghai, January 10, 2022—For six long years, 72-year-old Mr. Wu endured the relentless torment of chronic heart failure. Nights were spent gasping for breath, his sleep fragmented by crippling chest tightness. Diagnosed with severe mitral valve regurgitation, atrial fibrillation, and a host of comorbidities—including hypertension, diabetes, and a history of stroke—his condition defied conventional treatments.

As his health deteriorated last month, with his left ventricular ejection fraction plummeting to a critical 25%, hope seemed distant. Traditional open-heart surgery was deemed too risky due to his frail health. But a multidisciplinary team at Renji Hospital, affiliated with Shanghai Jiao Tong University School of Medicine, offered a groundbreaking solution: a one-stop minimally invasive procedure combining transcatheter mitral valve clipping and left atrial appendage closure, guided by advanced image fusion technology.

Precision Meets Innovation

Under the leadership of Professor Bu Jun, Director of Cardiology, a collaborative team spanning cardiology, cardiac imaging, radiology, anesthesiology, and intensive care meticulously planned the surgery. Using cutting-edge 3D fusion imaging (CTA + CBCT) and real-time echocardiography, they navigated the complexities of Mr. Wu’s heart.

The procedure began with the placement of the first MitraClip, precisely capturing the most severely leaking segment of the mitral valve. Post-clip echocardiography showed near-complete elimination of regurgitation in the targeted area. A second clip was then deployed parallel to the first, sealing the remaining leakage. With the mitral valve stabilized, the team seamlessly implanted a left atrial appendage closure device to mitigate stroke risks associated with atrial fibrillation

A Triumph of Teamwork and Technology

“This case exemplifies the power of multidisciplinary collaboration and precision imaging,” explained Professor Bu. Mitral valve regurgitation, a leading cause of heart failure, often leaves high-risk patients like Mr. Wu with limited options. Transcatheter mitral valve repair, while minimally invasive, demands exceptional skill and real-time imaging to navigate the heart’s intricate anatomy—a feat achievable only by a handful of centers nationwide.

For Mr. Wu, the results were transformative. Within hours, his vital signs stabilized, and his debilitating symptoms vanished. Now recovering comfortably, he looks forward to reclaiming his life—a outcome once deemed impossible.

Pioneering Hope for Complex Heart Conditions

This milestone underscores Renji Hospital’s leadership in structural heart disease innovation. By integrating image-guided therapies, the team has opened new doors for patients deemed “untreatable” due to age or comorbidities. As minimally invasive techniques evolve, stories like Mr. Wu’s offer a beacon of hope for millions battling complex cardiac conditions.

Renji Hospital, affiliated with Shanghai Jiao Tong University School of Medicine, continues to advance cardiovascular care through cutting-edge research and patient-centered innovation.